½ÉÀå µ¹¿¬»ç
Sudden Cardiac Death

´ëÇÑÀÇ»çÇùȸÁö 2010³â 53±Ç 3È£ p.214 ~ p.227

±è³²È£(Kim Nam-Ho) - ¿ø±¤´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
À±°æÈ£(Yun Kyeong-Ho) - ¿ø±¤´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
¿À¼®±Ô(Oh Seok-Kyu) - ¿ø±¤´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç

Abstract

½ÉÀå µ¹¿¬»ç(sudden cardiac death)´Â Á×À½ÀÌ °©ÀÛ½º ·´°Ô ¿¹±âÄ¡ ¸øÇÑ »óÅ¿¡¼­ ¹ß»ýÇß´Ù´Â °ÍÀ» ÀǹÌÇÏ ´Â °ÍÀ¸·Î °©ÀÛ½º·¯¿ò°ú ¿¹»óÇÏÁö ¸øÇÔÀÇ µÎ°¡Áö ¿ä¼Ò°¡ Á¸ ÀçÇÑ´Ù. ½Ã°£ÀûÀ¸·Î °©ÀÛ½º·¯¿òÀÇ ¹üÁÖ¸¦ ¾îµð±îÁö·Î ÀÎÁ¤ ÇÒ °ÍÀΰ¡´Â ÀúÀÚ ¹× ÇÐȸ¿¡ µû¶ó ¸Å¿ì ´Ù¾çÇϳª, ¼¼°èº¸°Ç ±â±¸¿¡¼­´Â Áúº´ÀÇ Áõ»óÀÌ ½ÃÀÛµÈ ÈÄ 24½Ã°£ À̳»¿¡ »ç¸ÁÇÏ ´Â °æ¿ì·Î Á¤ÀÇÇÏ°í ÀÖ´Ù. ÀÓ»óÀûÀ¸·Î´Â ¾î¶°ÇÑ Áúº´ ¶Ç´Â »óÅ°¡ ÀüÇô ¾øÀÌ Áõ»óÀÌ ¹ßÇöÇÏ¿© 1½Ã°£ À̳»¿¡ ¿¹±âÄ¡ ¾Ê °Ô »ç¸ÁÇÏ´Â °æ¿ì·Î Á¤ÀÇÇÏ°í ÀÖ´Ù(1). ½ÉÀ庴ÀÇ Æ¯¼º»ó ½É Ç÷°ü°è »ç¸Á ȯÀÚÀÇ 50%Á¤µµ°¡ ½ÉÀå µ¹¿¬»ç ÇüÅ·Π³ªÅ¸³ª ¸ç, Ư±âÇÒ °ÍÀº À̵é ȯÀÚÀÇ Àý¹Ý °¡·®¿¡¼­ ½ÉÀåÁúȯÀÇ Ã¹ Áõ»óÀ¸·Î ½ÉÀå µ¹¿¬»ç·Î ³ªÅ¸³­´Ù´Â °ÍÀÌ´Ù(2). ¹Ì±¹ Åë°è ¿¡ ÀÇÇÏ¸é ½ÉÀå µ¹¿¬»çÀÇ ¹ß»ý·üÀº ¿¬ 0.1~ 0.2%·Î 1³â¿¡ ¾à 20~40¸¸¸íÀÌ ½ÉÀå µ¹¿¬»ç·Î »ç¸ÁÇÏ°í ÀÖÀ¸¸ç, ÀÌ´Â ½É°¢ÇÑ »çȸ ¹®Á¦·Î ºÎ°¢µÇ°í ÀÖ´Ù(3). Áß±¹Àº Àα¸ ½Ê¸¸¸í´ç 41.8¸íÀÇ µ¹¿¬»ç À¯º´·üÀ» ¹ßÇ¥ÇÑ ¹Ù ÀÖ´Ù(4). ¿ì¸®³ª¶ó¿¡ ¼­´Â ÃÖ±Ù 20¿© ³â°£ °üµ¿¸ÆÁúȯÀ¸·Î Ä¡·á¸¦ ¹Þ°Å³ª »ç¸ÁÇÑ Àα¸°¡ ±Þ°ÝÈ÷ Áõ°¡ÇÑ °ÍÀ¸·Î º¸¾Æ ÀÌ ÁúȯÀÌ ÁÖ¿ä ¿øÀÎÀ¸·Î ¾Ë·ÁÁø ½ÉÀå µ¹¿¬»çµµ ±Þ°ÝÈ÷ Áõ°¡ÇÏ¿´À» °ÍÀ¸·Î ÃßÁ¤µÇ³ª, ¾ÆÁ÷ ±¹³» ¿ªÇÐÀ̳ª Åë°è°¡ Á¤È®È÷ ¹ßÇ¥µÈ ¹Ù´Â ¾ø´Ù.
Sudden cardiac death (SCD) refers to the unexpected natural death from a cardiac cause within a short time period, generally within an hour from the onset of symptoms, in a person without any prior fatal condition. Despite the tremendous advances in the field of cardiovascular medicine, the incidence of SCD continues to rise. In 60 to 80 percent of cases, SCD occurs in the patients with coronary artery disease. Most instances of SCD are thought to involve ventricular tachycardia degenerating to ventricular fibrillation and subsequent asystole. Since the implantable cardioverter defibrillator (ICD) is effective in terminating ventricular tachycardia and fibrillation, the application of ICD has increased markedly. However, the application of ICD needs to be individualized for the patient, similar to drug therapies in LV systolic dysfunction. This review discusses the current understanding on SCD, risk stratification, and management goals for reducing SCD, particularly with the ICD usage.

Å°¿öµå

½ÉÀå µ¹¿¬»ç, °üµ¿¸ÆÁúȯ, Á½ɽDZ¸ÃâºÐÀ², »ðÀÔÇü ½É½Ç Á¦¼¼µ¿±â
Sudden cardiac death, Coronary artery disease, Left ventricular ejection fraction, Implantable cardioverter defibrillator
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
The application of ICD needs to be individualized for the patient, similar to drug therapies in LV systolic dysfunction.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå